GLL 398
GLL 398 is a potent and selective oral estrogen receptor degrader, demonstrating an IC50 of 1.14 nM. It effectively inhibits tumor growth in breast cancer xenograft models, supporting its use in both in vitro mechanistic studies and in vivo preclinical research for hormone receptor-positive cancers.
Product Specifications
CAS Number
2077980-80-2
Field of Research
Metabolism Research
Smiles
CC/C (C1=CC=CC=C1) =C (C2=CC=C (B (O) O) C=C2) /C3=CC=C (C=C3) /C=C/C (O) =O
Molecular Formula
C25H23BO4
Molecular Weight
398.26
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6282678-01 0.2 mL
CCT7, NT (CCT7, CCTH, NIP7-1, T-complex protein 1 subunit eta, CCT-eta, HIV-1 Nef-interacting protein) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6282678-02 5x 0.2 mL
CCT7, NT (CCT7, CCTH, NIP7-1, T-complex protein 1 subunit eta, CCT-eta, HIV-1 Nef-interacting protein) (Azide free) (HRP)
Sign In for Pricing
View Details MBS2043659-01 0.1 mL
FITC-Linked Polyclonal Antibody to Endostatin (ES)
Sign In for Pricing
View Details MBS2043659-02 0.2 mL
FITC-Linked Polyclonal Antibody to Endostatin (ES)
Sign In for Pricing
View Details